NHS Bowel Cancer Screening: Full 2024-25 Data and Private Insurance Options

NHS Bowel Cancer Screening: The Headline Numbers

The NHS Bowel Cancer Screening Programme (BCSP) invites everyone in England aged 50 to 74 to complete a home FIT (faecal immunochemical test) every two years, a change fully phased in during 2025 after starting at age 60 in 2006 and expanding to 70-74 in 2010. In the 2024-25 screening year, 7,963,115 people were invited, of whom 5,195,407 adequately participated, an uptake of 65.2%. Of those screened, 89,030 had a result requiring further tests, a positivity rate of 1.71%.

Coverage, the proportion of the eligible population up to date with screening within the last 30 months, reached 72.9% as of March 2025, having climbed steadily from 56.0% in March 2014.

Who Gets Screened, and Who Doesn't

Uptake varies significantly by region. The South West has the highest FOBt uptake at 70.1%; London has the lowest, at 54.2%, more than 15 percentage points behind.

The gap by deprivation is even starker. People in the least deprived fifth of England are considerably more likely to take part in screening than those in the most deprived fifth.

Gender and age gaps are also measurable: 68.2% of women took part in 2024-25 compared with 62.3% of men, and uptake rises steadily with age, from 56.2% among newly-eligible 54-year-olds up to 73.5% among 70 to 74-year-olds.

Where the Programme Is Falling Short

Not every part of the programme meets its own targets. Of people who received a test kit result showing further tests were needed, only 76.0% went on to actually have a diagnostic test, below the 81% acceptable threshold set for the standard, and considerably below the 90% achievable level.

There is also a substantial gap between being offered a timely appointment and actually attending one. Nationally, 89.2% of people were offered a first diagnostic test appointment within 14 days of referral, just under the 90% acceptable threshold. But only 50.4% of people actually attended a diagnostic test within that same 14-day window, a considerably bigger shortfall that reflects both patient choice (people requesting later dates) and, in some regions, capacity constraints.

Pathology turnaround also missed its target nationally: 87.9% of polyps were reported on or within 7 days, against a 90% acceptable threshold, with performance ranging from 81.8% in North East & Yorkshire up to 95.3% in London.

What Happens If You're Referred

People with a positive FIT result are assessed by a Specialist Screening Practitioner (SSP) for fitness for further tests, usually a colonoscopy. The programme's clinical quality standards for 2024-25 were generally strong: a national adenoma detection rate of 59.4% (comfortably above the 50% achievable threshold), a caecal intubation rate of 96.2%, and a polyp retrieval rate of 97.9%. Around 5.7% of diagnostic procedures used CT colonography (a "virtual colonoscopy") rather than a traditional colonoscopy, typically for patients with specific clinical reasons for the alternative test.

Private Bowel Cancer Screening and Insurance: What's Actually Covered

The NHS programme only covers ages 50 to 74, tests every two years, and can involve waiting times for diagnostic follow-up, as the data above shows. This leads some people to look at private options, either through existing health insurance or by paying directly. It's worth understanding exactly what each route covers before assuming insurance will pay for it.

The key distinction: diagnostic vs preventative. Private medical insurance from providers such as Bupa, AXA Health, Aviva and Vitality typically covers colonoscopy when it's used to investigate new symptoms and you have a GP referral, treating it the same as any other diagnostic procedure. What standard PMI policies generally do not cover is routine preventative screening in someone with no symptoms, since insurers treat that as a health-maintenance service rather than treatment of a medical condition. Anyone relying on insurance to fund a "just to be safe" colonoscopy with no symptoms should check their specific policy wording, since assuming cover that isn't there can mean an unexpected bill or a declined claim.

For genuine preventative screening outside the NHS age range or 2-year interval, insurers and private hospital groups instead offer separate paid screening products, health assessments with a targeted cancer screening option, or standalone tests like a FIT kit or CT colonography, typically costing in the region of £300-£800 depending on the test and provider. A full self-pay diagnostic colonoscopy, if not going through insurance or the NHS, typically costs £1,849 to over £4,500 depending on the provider and whether it's an all-inclusive package.

Pre-existing condition moratoriums are a common complication: if you've previously been investigated for bowel symptoms, have inflammatory bowel disease, or have had polyps removed before taking out a policy, an insurer may treat a new colonoscopy request as related to a pre-existing condition and decline cover, even years later. Checking policy wording on this point before assuming cover applies is worthwhile for anyone with a prior bowel history.

NHS vs Private: Which Applies to You

If you're aged 50-74, have no symptoms, and are willing to test every two years, the free NHS programme is the appropriate route; it's also where any positive result leads into a properly integrated NHS diagnostic and treatment pathway. If you have symptoms such as changes in bowel habit, blood in stool, or unexplained weight loss, see a GP promptly regardless of age or screening status; symptomatic cases can be referred urgently under the two-week-wait pathway, and this is also the route private medical insurance is designed to support. If you want screening outside the NHS age range or interval purely as a precaution, with no symptoms, a paid private screening package, not standard health insurance, is the realistic option.

Frequently asked questions

What age does NHS bowel cancer screening start in 2026?

Age 50, following the full completion of the NHS age-expansion programme in 2025. It was previously 60, then extended to include 70-74 year olds from 2010, before the further expansion down to 50.

How many people take up NHS bowel cancer screening?

In 2024-25, 65.2% of those invited adequately participated, and 72.9% of the eligible population were up to date with screening as of March 2025.

Does private health insurance cover bowel cancer screening?

Generally, private medical insurance covers colonoscopy to investigate new symptoms with a GP referral, not routine preventative screening in someone with no symptoms. Preventative screening is usually a separate paid product.

How much does a private colonoscopy cost in the UK?

Typically £1,849 to over £4,500 for a self-pay diagnostic colonoscopy, depending on the provider and whether it's an all-inclusive package. Separate screening-only packages (such as a private FIT test or CT colonography) typically cost less, around £300-£800.

Why is there such a big gap between being offered and attending a diagnostic test?

NHS data shows 89.2% of people are offered an appointment within 14 days, but only 50.4% actually attend within that window. This reflects both patients requesting later dates and, in some regions, capacity constraints.